Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China · Delayed Price · Currency is CNY 25.52
+0.57 (2.28%)
Mar 6, 2026, 3:00 PM CST
Aurisco Pharmaceutical Market Cap
Aurisco Pharmaceutical has a market cap or net worth of 10.37 billion as of March 6, 2026. Its market cap has increased by 25.16% in one year.
Market Cap
10.37B
Enterprise Value
10.32B
Revenue
1.62B
Ranking
n/a
PE Ratio
24.01
Stock Price
25.52
Market Cap Chart
Since September 21, 2020, Aurisco Pharmaceutical's market cap has increased from 4.83B to 10.37B, an increase of 114.52%. That is a compound annual growth rate of 15.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 10.37B | 1.87% |
| Dec 31, 2025 | 10.18B | 18.61% |
| Dec 31, 2024 | 8.58B | -18.20% |
| Dec 29, 2023 | 10.49B | 4.58% |
| Dec 30, 2022 | 10.03B | 13.58% |
| Dec 31, 2021 | 8.83B | 38.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Hotgen Biotech | 11.90B |
| Chengdu Olymvax Biopharmaceuticals | 11.88B |
| Hualan Biological Vaccine | 11.55B |
| Chengzhi | 10.85B |
| HitGen | 10.83B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 10.70B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.27B |
| Liaoning Chengda Biotechnology | 10.25B |